Application of viable rhodomonas mucilaginosa preparation and exopolysaccharide in preparation of medicine for relieving skin injury caused by UVB (Ultraviolet B)

By using viable Rosomia mucinous preparations and extracellular polysaccharides, the skin damage caused by UVB radiation was solved, which significantly reduced the cellular oxidative stress and inflammatory factors transcription levels, inhibited cell apoptosis, and improved UVB-induced skin Injury, it provides an effective drug regimen to relieve UVB skin damage.

CN118987049APending Publication Date: 2024-11-22HOSPITAL OF DERMATOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410778222.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-17
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing technology is difficult to effectively alleviate skin damage caused by UVB radiation, including sunburn, colorectal depression and skin squamous cell carcinoma.

Method used

Using Roseomonas mucosa live bacteria preparation and its extracellular polysaccharides, live bacteria preparation and extracellular polysaccharides are prepared through specific culture media and preparation methods to reduce oxidative stress and inflammation of HaCaT cells caused by UVB. Factor transcription level, inhibits apoptosis and improves skin lesions.

Benefits of technology

Effectively reduce the oxidative stress and apoptosis of HaCaT cells caused by UVB radiation, inhibit the transcription level of skin inflammatory factors, improve UVB-induced skin erythema, edema, exudation and scabs, and significantly alleviate acute skin inflammation caused by UVB.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987049A_ABST
    Figure CN118987049A_ABST
Patent Text Reader

Abstract

The invention discloses application of a skin symbiotic bacterium rhodomonas mucilaginosa viable bacterium preparation in relieving skin injury caused by UVB (Ultraviolet B), and further provides application of extracellular polysaccharide prepared on the basis of the skin symbiotic bacterium rhodomonas mucilaginosa viable bacterium preparation in relieving the skin injury caused by UVB. Results show that in a model of keratinocyte inflammation caused by UVB, the rhodomonas mucilaginosa DL-1 viable bacterium preparation and the exopolysaccharide thereof have a protection effect on keratinocyte apoptosis caused by UVB, oxidative stress and inflammatory response caused by UVB can be reduced, cell apoptosis caused by UVB can be reduced, and the application of the rhodomonas mucilaginosa DL-1 viable bacterium preparation and the exopolysaccharide thereof in the treatment of keratinocyte inflammation caused by UVB can be Meanwhile, the rhodomonas mucilaginosa DL-1 viable bacterium preparation and the exopolysaccharide thereof can relieve acute injuries such as epidermis thickening, inflammation infiltration and the like of the backs of C57 / BL6 mice caused by UVB. The rhodomonas mucilaginosa DL-1 viable bacterium preparation and the exopolysaccharide thereof have a relatively good repairing effect on UVB-induced acute skin injury, and have a good application prospect in resisting related diseases caused by UVB.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention is a divisional application of application number 2023105558901 filed on May 17, 2023, and the invention name is "Application of live preparations of Roseomonas mucilaginosa and extracellular polysaccharides in the preparation of drugs for alleviating skin damage caused by UVB." Technical Field

[0002] The invention relates to the field of medical technology, and in particular to an application of a live bacterial preparation of skin symbiotic bacteria Roseomonas mucilaginosa and exopolysaccharides in preparing a medicine for alleviating skin damage caused by UVB. Background Art

[0003] As air pollution worsens year by year, the ozone layer has been severely damaged, and the ultraviolet radiation to the earth's surface has increased significantly, affecting people's quality of life. UVB in sunlight can cause a series of skin diseases such as sunburn, pigmentation and squamous cell carcinoma of the skin. Keratinocytes (HaCaT) on the skin are the main components of the epidermis. HaCaT cells are the main target of UVB in the epidermis. UVB is almost completely absorbed by HaCaT cells, which can induce HaCaT cells to produce excessive reactive oxygen species (ROS), destroy their own antioxidant defense system, cause lipid peroxidation, affect related signal transduction pathways, and damage cell structure or function. UVB irradiation can cause them to secrete a variety of inflammatory factors such as interleukin-6 (IL-6) and interleukin-1β (IL-1β) to mediate inflammatory responses, regulate immune responses, and induce cell apoptosis and other cell physiological activities, which in turn cause adverse skin manifestations such as erythema, redness, sagging, dryness, desquamation, and pigmentation. Summary of the invention

[0004] Purpose of the invention: In order to solve the problem of skin damage caused by UVB, the present invention provides a live bacterial preparation of skin commensal bacteria Roseomonas mucosa (R. mucosa) and an extracellular polysaccharide for the preparation of a drug for alleviating skin damage caused by UVB.

[0005] The invention further provides a preparation method of a live bacterial preparation of Roseomonas mucilaginosa and an extracellular polysaccharide.

[0006] The present invention further provides the effects of live bacterial preparations of skin commensal bacteria Roseomonas mucilaginosa and exopolysaccharides in alleviating the transcription level detection of inflammatory factors and pathophysiological states of acute back injuries in HaCaT cells and mice caused by UVB.

[0007] Specifically, the present invention proposes the use of a live bacterial preparation of Roseomonas mucilaginosa in the preparation of a drug for alleviating skin damage caused by UVB. The live bacterial preparation of Roseomonas mucilaginosa is prepared by the following method: inoculating Roseomonas mucilaginosa into an R2A culture medium, activating at 25-37° C. for 12-24 hours, transferring the activated Roseomonas mucilaginosa into a fermentation culture medium, culturing at 30-37° C. for 24-36 hours to obtain a fermentation broth, centrifuging the fermentation broth, and then resuspending the thalli in a dosing solvent to obtain the live bacterial preparation; wherein the dosing solvent is any one of propylene glycol and propylene glycol.

[0008] The classification number of the mucus roseomonas is mucus roseomonas (Roseomonas mucosa, also recorded as R.mucosa), the strain number is DL-1, and it has been deposited in the General Microbiological Center of the China General Microbiological Culture Collection Administration Committee on October 26, 2022, and the deposit number is CGMCC No. 25967. This strain is a skin commensal bacteria strain screened from healthy human skin by the inventor in November 2021.

[0009] Among them, the components of R2A culture medium are: yeast extract powder 0.5g / L, peptone 0.5g / L, casein hydrolysate 0.5g / L, glucose 0.5g / L, soluble starch 0.5g / L, dipotassium hydrogen phosphate 0.3g / L, anhydrous magnesium sulfate 0.024g / L, sodium pyruvate 0.3g / L, agar 15.0g / L, pH 7.2.

[0010] Preferably, the fermentation medium is formulated as follows: carbon source 10-100 g / L, nitrogen source 1-30 g / L, inorganic salt 0.01-50 g / L, pH 5.0-9.0, and the solvent is water.

[0011] The carbon source is any one or more combinations of glucose, sucrose, maltose, lactose, xylose, fructose, lactic acid, citric acid, glycerol, starch and molasses, preferably any one or more combinations of sucrose, glucose, lactose, citric acid and starch; the nitrogen source is any one or more combinations of yeast extract, beef extract, peptone, yeast extract, corn steep liquor, soybean cake powder, cottonseed cake powder, urea, (NH4)2SO4, NH4Cl, (NH4)2HPO4 and NH4NO3, preferably any one or more combinations of peptone, yeast extract, corn steep liquor, (NH4)2SO4, NH4Cl, (NH4)2HPO4 and NH4NO3; the inorganic salt is any one or more combinations of sodium chloride, sulfate, phosphate, dihydrogen phosphate, dihydrogen phosphate and hydrochloride.

[0012] In a preferred embodiment, the fermentation medium components are 17.0 g / L tryptone, 3.0 g / L soy peptone, 5.0 g / L sodium chloride, 2.5 g / L dipotassium hydrogen phosphate, 2.5 g / L glucose, and the pH value is 7.3.

[0013] The number of viable Roseomonas mucilaginosa in the viable bacterial preparation is 1×10 6 -1×10 9 CFU / mL.

[0014] Preferably, the viable count of Roseomonas mucilaginosa is 1×10 5 -1×10 7 CFU / mL; more preferably, the viable count of Roseomonas mucilaginosa is 1×10 5 -1×10 6 CFU / mL.

[0015] The results of the study showed that the live bacterial preparation of R. mucilaginosa reduced the oxidative stress level and cell apoptosis of HaCaT cells caused by UVB irradiation.

[0016] The live bacterial preparation of Roseomonas mucilaginosa improves skin lesions on the back of C57BL / 6 mice induced by UVB irradiation, including erythema, edema, exudation and scab, inhibits apoptosis of keratinocytes in the back skin lesions caused by UVB irradiation, and reduces the transcription level of inflammatory factors in the skin lesions.

[0017] The present invention further proposes the use of Roseomonas mucilaginosa exopolysaccharide in the preparation of a medicine for alleviating skin damage caused by UVB. The Roseomonas mucilaginosa exopolysaccharide is prepared by the following method: inoculating Roseomonas mucilaginosa CGMCC 25967 in an R2A culture medium, activating at 25-37°C for 12-24h, transferring the activated Roseomonas mucilaginosa to a fermentation culture medium, culturing at 30-37°C for 24-36h to obtain a fermentation broth, and subjecting the fermentation broth to sterilization, protein removal, anhydrous ethanol precipitation, and DEAE centrifugal exchange resin separation and purification to obtain the exopolysaccharide.

[0018] Specifically, the mixture was sterilized by centrifugation at 3000-5000 rpm for 10 min, 1 / 2 volume of sevage reagent was added to remove protein 3 times, 1 volume of anhydrous ethanol was added and incubated at 4°C overnight to obtain a crude extracellular polysaccharide precipitate, which was re-dissolved with deionized water, separated and purified by DEAE-52, and then freeze-dried to obtain an extracellular polysaccharide (hereinafter referred to as R. mucosa DL-1EPS and DL-EPS have the same meaning).

[0019] The weight average molecular weight of the extracellular polysaccharide is 3000-3500 Da, and the monosaccharide composition thereof comprises arabinose, rhamnose, galactose, glucose, xylose, mannose, ribose, galacturonic acid, glucuronic acid, mannuronic acid and guluronic acid.

[0020] In some specific embodiments, the monosaccharide composition of the extracellular polysaccharide is: arabinose: rhamnose: galactose: glucose: xylose: mannose: ribose: galacturonic acid: glucuronic acid: mannuronic acid: guluronic acid = 0.50-0.6:1.3-1.5:1.3-2:72-78:4-7:9-11:0.9-1.1:0.5-2.4:0.6-1.4:0.6-1.4:0.9-1.7.

[0021] The present application study found that the extracellular polysaccharide of Roseomonas mucilaginosa also has good application prospects in alleviating UVB-induced related diseases, photoaging and after-sun repair.

[0022] Specifically, the Roseomonas mucilaginosa exopolysaccharide reduces the oxidative stress and apoptosis of HaCaT cells caused by UVB irradiation, and reduces the transcription level of inflammatory factors in HaCaT cells induced by UVB irradiation; the Roseomonas mucilaginosa exopolysaccharide inhibits the increase in the transcription level of type I interferon IFN-β caused by UVB irradiation; the Roseomonas mucilaginosa exopolysaccharide improves UVB irradiation-induced erythema, edema, exudation and scab on the back skin of C57BL / 6 mice, inhibits the apoptosis of keratinocytes in the back skin lesions caused by UVB irradiation, and reduces the transcription level of inflammatory factors in the skin lesions.

[0023] Specifically, the dosage of DL-EPS in the cell model was 0.5-4.5 mg / mL, and the dosage for topical treatment of UVB-induced C57 / BL6 acute model was 0.1-0.5 mg / cm 2 .

[0024] The live bacteria preparation of Roseomonas mucilaginosa and the extracellular polysaccharide can be used in combination with antibiotic-free drugs and skin care products, or can be used alone.

[0025] Beneficial effect: This application proposes that the live bacterial preparation of skin commensal bacteria R. mucosa DL-1 and the extracellular polysaccharide DL-EPS can antagonize the oxidative stress response of HaCaT cells induced by UVB irradiation, and at the same time reduce 50mJ / cm 2 UVB-induced transcriptional levels of inflammatory factors in HaCaT cells, reduced by 50 mJ / cm 2 UVB-induced apoptosis of HaCaT cells was effectively alleviated by 430mJ / cm 2UVB-induced pathological changes in the macroscopic and microscopic skin lesions of C57BL / 6 mice can be inhibited by 430 mJ / cm 2 The transcription of important inflammatory factors IL-1, IL-6 and TNF- in the skin lesions of C57BL / 6 mice induced by UVB. The skin commensal bacteria R. mucosa live bacterial preparation and exopolysaccharide described in the present invention have a certain protective effect on the apoptosis of epidermal keratinocytes caused by UVB, thereby improving acute skin inflammation caused by UVB. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 Biological characteristics of Roseomonas mucilaginosa; A: colony morphology, B Gram staining, C: scanning electron micrograph, D: phylogenetic tree analysis of 16S rRNA sequence;

[0027] Figure 2 This is the elution curve of the exopolysaccharide DL-EPS of Roseomonas mucilaginosa DL-1;

[0028] Figure 3 is the ion chromatogram of the standard sample;

[0029] Figure 4 This is the ion chromatogram of the extracellular polysaccharide DL-EPS sample;

[0030] Figure 5 This is the scattering spectrum of the extracellular polysaccharide DL-EPS sample;

[0031] Figure 6 This is a graph showing the effects of live bacterial preparations of skin commensal bacteria R. mucosa DL-1 and extracellular polysaccharide DL-EPS on the toxicity of HaCaT cells;

[0032] Figure 7 The live bacterial preparation of skin commensal bacteria R. mucosa DL-1 was used for 50mJ / cm 2 The results of the effect of UVB irradiation on reactive oxygen species;

[0033] Figure 8 The effect of R. mucosa DL-1 extracellular polysaccharide DL-EPS on 50mJ / cm 2 The results of the effect of UVB irradiation on reactive oxygen species;

[0034] Fig. 9 The extracellular polysaccharide DL-EPS of skin commensal bacteria R. mucosa DL-1 was 50mJ / cm 2The results of the effect of UVB irradiation on the transcriptional levels of the main inflammatory factors IL-6, IL-1β, TNF-α and IFN-β in HaCaT cells (significant marks: *, P<0.05; **, P<0.01, ***, P<0.001; ****, P<0.0001)

[0035] Fig.10 The extracellular polysaccharide DL-EPS of skin commensal bacteria R. mucosa DL-1 was 50mJ / cm 2 The results of the apoptosis of HaCaT cells induced by UVB irradiation;

[0036] Fig.11 The live bacterial preparation of R. mucosa DL-1 and the extracellular polysaccharide DL-EPS were used to treat 430mJ / cm 2 The effects of UVB irradiation on the pathology of macroscopic and microscopic skin lesions on the back of C57BL / 6 mice;

[0037] Fig.12 The live bacterial preparation of R. mucosa DL-1 and the extracellular polysaccharide DL-EPS were used to treat 430mJ / cm 2 The results of the effect of UVB irradiation on the transcriptional levels of inflammatory factors in the back skin lesions of C57BL / 6 mice (significant marks: *, P<0.05; **, P<0.01, ***, P<0.001; ****, P<0.0001);

[0038] Fig.13 The live bacterial preparation of R. mucosa DL-1 and the extracellular polysaccharide DL-EPS were used to treat 430mJ / cm 2 The results of the effect of UVB irradiation on apoptosis of keratinocytes in the back epidermis of C57BL / 6 mice (blue, DAPI; red, PI; green, Pan Cytokeratin). DETAILED DESCRIPTION

[0039] Example 1 Fermentation of Roseomonas mucosa DL-1.

[0040] The mucilaginous Roseomonas DL-1 stored on a slant at 4°C was activated and inoculated on a seed culture medium (i.e., activation culture medium) at an activation temperature of 32°C for 16 hours. 10% of the seed fermentation liquid was inoculated into the fermentation medium at a rotation speed of 200 rpm and cultured at 32°C for 24 hours to obtain a fermentation liquid. The number of live bacteria in the fermentation liquid could reach 5×10 9 CFU / mL and above.

[0041] The activation medium is R2A medium, and the medium components are: 0.5 g / L yeast extract powder, 0.5 g / L peptone, 0.5 g / L casein hydrolyzate, 0.5 g / L glucose, 0.5 g / L soluble starch, 0.3 g / L dipotassium hydrogen phosphate, 0.024 g / L anhydrous magnesium sulfate, 0.3 g / L sodium pyruvate, 15.0 g / L agar, and the pH value is 7.2. The fermentation medium components are 17.0 g / L tryptone, 3.0 g / L soy peptone, 5.0 g / L sodium chloride, 2.5 g / L dipotassium hydrogen phosphate, 2.5 g / L glucose, and the pH value is 7.3.

[0042] Among them, Roseomonas mucilaginosa DL-1 is a skin commensal bacteria screened by the inventor from healthy human skin. Roseomonas mucilaginosa DL-1 has the following properties:

[0043] 1) Colony morphology

[0044] After culturing in R2A medium at 32°C for 16-24 hours, the colonies were observed under a microscope as single colonies with the following morphology: Figure 1 A. Gram staining was performed and the results were as follows Figure 1 As shown in B, it is club-shaped and belongs to Gram-negative bacteria. Scanning by electron microscope shows that the morphology is Figure 1 As shown in C, a large amount of biofilm can be secreted, and it has flagella and can move. In the above culture medium, the bacteria can grow in large quantities at 32°C for 12 hours, produce red pigment, and have a mucus-like morphology, and are arranged in single, paired or short chains. The temperature range of its growth is 5-40°C, the optimum temperature is 30-35°C, the pH range of its growth is 5.0-9.5, and the optimum pH is 6.5-7.5. It can grow normally in LB, R2A, TSB, BAB and other culture media.

[0045] 2) 16S rDNA sequence analysis

[0046] The length of the 16S rDNA sequence is 1464 bp. The 16S rDNA sequence was compared with the related species in the GeneBank database to construct a phylogenetic tree based on the complete 16S rDNA sequence. Figure 1 D. The results show that the similarity between strain DL-1 and Roseomonas mucosa reaches 99.86%. Therefore, the strain of the present invention is identified as Roseomonas mucosa, which is classified as Rhodospirillales, Acetobacteraceae, strain number DL-1, and has been deposited in the General Microbiological Center of China General Microbiological Culture Collection Committee, the deposit time is October 26, 2022, and the deposit number is CGMCC No.25967.

[0047] Example 2 Preparation of live bacterial preparation of R. mucosa DL-1 and extracellular polysaccharide DL-EPS.

[0048] The fermentation broth in Example 1 was centrifuged (9000 rpm, 10 min) and then the cells were resuspended in propylene glycol to obtain a live bacteria preparation. The number of live bacteria reached 1×10 9 CFU / mL.

[0049] The fermentation broth in Example 1 was centrifuged (3000-4000rpm, 10min) to sterilize, and 1 volume of the fermentation broth was added to 2 volumes of sevage reagent (chloroform: n-butanol = 4:1), and the reaction was repeated 2-3 times to remove the protein, and then 1 volume of anhydrous ethanol was added, and the mixture was centrifuged overnight at 4°C (3000-4000rpm, 10min) to obtain a crude exopolysaccharide precipitate, which was then dried and re-dissolved in deionized water. About 5-6g of the crude exopolysaccharide was separated and purified by DEAE centrifugal exchange resin using the sulfuric acid-phenol method, and the elution curve was as shown in FIG. Figure 2 As shown, the 0.2 M NaCl elution fractions were collected and freeze-dried, and the monosaccharide composition and molecular weight of the extracellular polysaccharide DL-EPS were determined.

[0050] The method for determining the monosaccharide of extracellular polysaccharide DL-EPS is as follows: Thermo ICS5000 ion chromatography system (ICS5000, Thermo Fisher Scientific, USA) uses an electrochemical detector to analyze and detect the monosaccharide components of the mixed standard and sample. After accurately weighing the standard products required for this project, add water to make a 10 mg / mL standard solution mother solution single standard, then take an appropriate amount of the standard mother solution single standard and mix it to make a standard mixed standard with a maximum index concentration of 60 μg / mL, 50 μg / mL or 40 μg / mL, and prepare the series of standards required for the machine according to the following concentration gradient.

[0051] Table 1. Monosaccharide standard gradient concentration information

[0052]

[0053] *Standard products mainly come from Sigma

[0054] Using Dionex TM CarboPac TMPA20 (150*3.0mm, 10μm) liquid chromatography column; injection volume is 5μl. Mobile phase A (H2O), mobile phase B (0.1 M NaOH), mobile phase C (0.1 M NaOH, 0.2 M NaAc), flow rate 0.5 ml / min; column temperature was 30°C; elution gradient: 0 min A phase / B phase / C phase (95:5:0, V / V), 26 min A phase / B phase / C phase (85:5:10, V / V), 42 min A phase / B phase / C phase (85:5:10, V / V), 42.1 min A phase / B phase / C phase (60:0:40, V / V), 52 min A phase / B phase / C phase (60:40:0, V / V), 52.1 min A phase / B phase / C phase (95:5:0, V / V), 60 min A phase / B phase / C phase (95:5:0, V / V).

[0055] The results of standard determination are as follows Figure 3 As shown in the figure, all 13 standards have single peaks. Figure 4 As shown, according to the standard curve of standard retention time and sample concentration, the monosaccharide composition of extracellular polysaccharide DL-EPS was determined to be arabinose: rhamnose: galactose: glucose: xylose: mannose: ribose: galacturonic acid: glucuronic acid: mannuronic acid: guluronic acid = 0.51:1.47:1.8:73.98:4.67:9.96:0.94:2.33:1.35:1.32:1.67.

[0056] The molecular weight determination method of extracellular polysaccharide DL-EPS is as follows: the chromatographic system used is gel chromatography-differential-multi-angle laser light scattering system, the liquid phase system is U3000 (Thermo, USA), the differential detector is Optilab T-rEX (Wyatt technology, CA, USA), and the laser light scattering detector is DAWN HELEOSⅡ (Wyatt technology, CA, USA). Gel exclusion chromatography columns (Ohpak SB-805HQ (300×8mm), Ohpak SB-804HQ (300×8mm) and OhpakSB-803HQ (300×8mm) are connected in series. The column temperature is 45°C, the injection volume is 100μL, the mobile phase is A (0.02% NaN3, 0.1M NaNO3), the flow rate is 0.4mL / min, and the elution gradient is: isocratic, 100min. The results are as follows Figure 5 As shown, the retention time of the extracellular polysaccharide DL-EPS sample is 63.5 min. According to the Mark-Houwink equation, the weight average molecular weight of the extracellular polysaccharide DL-EPS is 3500 Da, and it is detected as a single peak, which is determined to be a pure extracellular polysaccharide DL-EPS.

[0057] Example 3 Evaluation of the cytotoxicity of live bacterial preparation of R. mucosa DL-1 and extracellular polysaccharide DL-EPS.

[0058] HaCaT cells were cultured at 1×10 5 After 3 h of inoculation of cells / well in a 96-well plate, the cells were treated with a final concentration of 1×10 3 -1×10 6 cfu / mL different concentrations of mucosa R.mucosa DL-1 and 0.06-4.5mg / mL different concentrations of exopolysaccharide DL-EPS were treated, and the empty cell culture medium was added as a control, and incubated in a 5% CO2 incubator for 24h. 10μL CCK8 solution was added to each well of the plate, and the culture plate was incubated in the incubator for 1-4 hours, and then the absorbance at 450nm was measured using a microplate reader (Agilent BioTek, SYNERGY / H1). The results are shown in Figure 6 As shown, 1×10 3 -1×10 6 cfu / mL R. mucosa DL-1 and 0.06-4.5 mg / mL extracellular polysaccharide DL-EPS had no significant effect on the viability of HaCaT cells, indicating that R. mucosa DL-1 and its extracellular polysaccharide DL-EPS are safe in this concentration range.

[0059] Example 4 Effect of live bacterial preparation of R. mucosa DL-1 and extracellular polysaccharide DL-EPS on 50 mJ / cm 2 Effects of UVB irradiation on reactive oxygen species in HaCaT cells.

[0060] HaCaT cells were plated in six-well culture plates in 2 mL of DMEM medium containing 10% FBS, with a cell concentration of 3.5 × 10 5 cell / well, and after culturing for 3 h, the skin commensal bacteria R. mucosa DL-1 live bacterial preparation obtained in Example 2 was added at 1×10 4 CFU / mL and 1×10 6 CFU / mL, and the concentration of DL-EPS of skin commensal bacteria R. mucosa DL-1 was 0.5μg / mL and 5μg / mL. After 4h of co-culture, 50mJ / cm 2 UVB irradiation (Sigma irradiation equipment SS-07B (1201B) (280-320 nm) calibrated according to Radiometer SOLAR irradiator, probe PMA2100) was performed for 24 hours to measure active oxygen.

[0061] Reactive oxygen species determination method: DCFH-DA (SLOAR, CA1410) was diluted with serum-free culture medium at a ratio of 1:1000 to a final concentration of 10 μmol / L. The cell culture medium was removed and an appropriate volume of diluted DCFH-DA was added. 1 mL of diluted DCFH-DA was added to one well of a six-well plate. Incubate in a 37°C cell culture incubator for 20 minutes. Wash the cells three times with serum-free cell culture medium to fully remove the DCFH-DA that did not enter the cells. The level of intracellular reactive oxygen species in each group was analyzed using a fluorescence microscope. The results are shown in Figure 2. Figure 7 and Figure 8 As shown, 50mJ / cm 2 Reactive oxygen burst in HaCaT cells after UVB treatment, live bacterial preparation of R. mucosa DL-1 1×10 4 CFU / mL and 1×10 6 CFU / mL and 0.5μg / mL and 5μg / mL extracellular polysaccharide DL-EPS to 50mJ / cm 2 It has a significant inhibitory effect on the reactive oxygen species induced by UVB irradiation in HaCaT cells, and reduces the level of oxidative stress in HaCaT cells caused by UVB irradiation.

[0062] Example 5: Effect of extracellular polysaccharide DL-EPS of skin commensal bacteria R. mucosa DL-1 on 50 mJ / cm 2 Effect of UVB irradiation on the transcription levels of the main inflammatory factors IL-6, IL-1β, TNF-α and IFN-β in HaCaT cells.

[0063] HaCaT cells were plated in six-well culture plates containing 2 mL of DMEM medium containing 10% FBS, with a cell density of 3.5 × 10 5 cell / well, and after 12 h of culture, the skin symbiotic bacteria R. mucosa DL-1 extracellular polysaccharide DL-EPS obtained in Example 2 was added at concentrations of 0.5 μg / mL and 5 μg / mL. After 4 h of co-culture, 50 mJ / cm 2UVB irradiation (Sigma irradiation equipment SS-07B (1201B) (280-320nm) according to Radiometer SOLAR irradiator, probe PMA2100 for calibration), after 4 hours of irradiation, add the same amount of extracellular polysaccharide DL-EPS again for overnight treatment, collect cells after 24 hours of UVB treatment, and extract total RNA of HaCaT cells using TRIZOL kit. Total RNA was reverse transcribed into cDNA using reverse transcription kit, and the target mRNA expression level was detected on ABIPrism 7900 real-time quantitative PCR instrument using SYBR Green kit. β-actin was used as an internal reference, and the relative expression of mRNA of the target gene was based on 2 -ΔΔCt calculate.

[0064] like Fig. 9 As shown, 50mJ / cm 2 UVB irradiation of HaCaT cells can significantly increase the transcription levels of IL-6, IL-1β, TNF-α and IFN-β in HaCaT cells. The extracellular polysaccharide DL-EPS of skin commensal bacteria R. mucosa DL-1 at concentrations of 0.5μg / mL and 5μg / mL can inhibit the increase in the transcription levels of inflammatory factors IL-6, IL-1β and TNF-α induced by UVB irradiation, and inhibit the increase in the transcription level of type I interferon IFN-β caused by UVB irradiation.

[0065] Example 6: Effect of Roseomonas mucosa DL-1 extracellular polysaccharide DL-EPS on 50 mJ / cm 2 Effects of UVB irradiation on apoptosis of HaCaT cells.

[0066] The cell test was set up as in Example 4, analyzing 50 mJ / cm 2 Apoptosis of HaCaT cells after UVB treatment for 24 hours. The cells were treated with a cell apoptosis detection kit (Biolegend, 640914) according to the recommended staining steps and analyzed by flow cytometry. Fig.10 As shown, 50mJ / cm 2 UVB irradiation of HaCaT cells can cause massive apoptosis of cells. Both 0.5μg / mL and 5μg / mL DL-EPS can significantly inhibit the apoptosis of HaCaT cells induced by UVB irradiation.

[0067] Example 7: Live bacterial preparation of R. mucosa DL-1 and extracellular polysaccharide DL-EPS to 430 mJ / cm 2 Effects of UVB irradiation on the pathology of macroscopic and microscopic skin lesions on the back of C57BL / 6 mice.

[0068] Animal experiment design: A total of 28 C57BL / 6J mice, aged 7 weeks, were randomly divided into 7 groups. All groups of mice were treated with drugs 24 hours after shaving their backs. The seven groups were healthy control group (no treatment, NC), UVB modeling group (UVB), positive control group (hydrocortisone 50 mg / 4 cm 2 / day, UVB+Hydr), matrix group (100% propylene glycol, UVB+Vehicle), high-dose group (1mg / 4cm 2 / day, UVB+EPS-H), low-dose group (0.5mg / 4cm 2 / day, UVB+EPS-L), live bacteria treatment group (10 9 cfu / 4cm 2 / day, UVB+DL-1), UVB 430mJ / cm3 after treatment 2 The back was irradiated, and medication was continued and observation was continued until 48 hours of UVB irradiation.

[0069] Statistical analysis method: 48 hours after exposure, the mice were sacrificed and the rash on the back of the mice was observed. The experimental results are shown in the attached Fig.11 The UVB modeling group can cause skin erythema, edema, exudation and scab, forming diffuse skin lesions. Compared with the matrix group, hydrocortisone in the positive group can significantly reduce the skin erythema, edema, exudation and scab caused by acute UVB irradiation. In the experimental group, 0.5 mg / 4 cm 2 / day DL-EPS and live bacteria preparations of Roseomonas mucilaginosa DL-1 can alleviate skin erythema, edema, exudation and crusting caused by acute UVB irradiation in mice, with only focal skin lesions. It has broad application prospects in skin diseases caused by UVB.

[0070] Example 8: Live bacterial preparation of R. mucosa DL-1 and extracellular polysaccharide DL-EPS to 430 mJ / cm 2 Effect of UVB irradiation on the transcription of the main inflammatory factors IL-6, IL-1β and TNF-α in the back skin lesions of C57BL / 6 mice.

[0071] After the mice in Example 7 were sacrificed, the skin lesions were taken and ground using a tissue grinder. The total RNA of HaCaT cells was extracted using a TRIZOL kit. The total RNA was reverse transcribed into cDNA using a reverse transcription kit, and the target mRNA expression level was detected on an ABI Prism 7900 real-time quantitative PCR instrument using a SYBR Green kit. β-actin was used as an internal reference, and the relative expression of the target gene mRNA was calculated according to 2 -ΔΔCt calculate.

[0072] The results are as follows Fig.12 As shown in the data, acute UVB irradiation can cause a significant increase in the transcription levels of the main inflammatory factors IL-6 and IL-1β in the skin lesions. Compared with the matrix treatment group, mice treated with hydrocortisone, high-dose DL-EPS, low-dose DL-EPS and live bacteria preparation of Roseomonas mucilaginosa DL-1 can inhibit the increase in the transcription levels of the main inflammatory factors IL-6 and IL-1β in the skin lesions caused by acute UVB irradiation, and there are statistical differences. Among them, low-dose DL-EPS treatment has the most significant effect in inhibiting the increase in the transcription levels of acute inflammatory factors caused by UVB.

[0073] Example 9: Effect of live bacterial preparation of R. mucosa DL-1 and extracellular polysaccharide DL-EPS on 430 mJ / cm 2 Effect of UVB irradiation on apoptosis of epidermal keratinocytes in the back skin lesions of C57BL / 6 mice.

[0074] Immunofluorescence staining method for mouse skin tissue:

[0075] 1) Take out the mouse back skin lesion tissue from the -80°C freezer, embed it with OCT, and cut the tissue into 5 mm slices using a freezing microtome;

[0076] 2) Place the slides in a humidified chamber to rewarm for 10 minutes;

[0077] 3) Place the tissue sections in PBS and place on a horizontal shaker at 80 rpm for 5 min each time, for a total of 3 times;

[0078] 4) After shaking the slice, wipe off the PBS around the tissue with a paper towel and draw a circle around the tissue with an immunohistochemistry pen;

[0079] 5) Add rapid immunostaining blocking solution and incubate at room temperature for 10 min;

[0080] 6) Wash twice with PBS, 5 min each time;

[0081] 7) Add anti-pancytokeratin primary antibody (1:100 dilution, abcam, catalog number ab8068) diluted with immunostaining primary antibody diluent on the tissue surface and incubate overnight at 4°C in a humidified box;

[0082] 8) Wash with PBS 3 times, 80 rpm, 5 min each time;

[0083] 9) Add Alexa Fluor 488-conjugated goatant-rabbite secondary antibody (1:200 dilution, vector lab, catalog number DI-1488-1.5) diluted with secondary antibody diluent to the tissue surface and incubate at room temperature in the dark for 60 minutes;

[0084] 10) Wash with PBS 3 times, 80 rpm, 5 min each time;

[0085] 11) Add propidium iodide (PI) / RNase staining solution (Cell Signaling Technology, 4087S) staining solution onto the tissue and incubate at room temperature in the dark for 15 minutes;

[0086] 12) Wash with PBS 3 times, 80 rpm, 5 min each time;

[0087] 13) Add two drops of DAPI-containing mounting medium on the tissue, incubate at room temperature in the dark for 5 minutes, and then observe under a fluorescence confocal microscope after mounting.

[0088] The results are as follows Fig.13 As shown, the total dose is 430mJ / cm 2 After UVB irradiation, typical apoptosis of epidermal keratinocytes occurred in both the UVB model and the matrix group. The positive drug hydrocortisone treatment and high-dose exopolysaccharide treatment groups could significantly alleviate UVB-induced keratinocyte apoptosis. The low-dose exopolysaccharide and Roseomonas mucilaginosa DL-1 live bacterial preparation treatment groups had a tendency to improve UVB-induced keratinocyte apoptosis.

[0089] The present invention provides a skin commensal bacterium Roseomonas mucosa live bacterial preparation and a method for preparing its extracellular polysaccharide, and further provides its application in alleviating UVB-induced acute skin damage. That is, the R. mucosa live bacterial preparation and the separated extracellular polysaccharide are used to treat UVB-irradiated HaCaT and UVB-induced acute back damage of C57 / BL6 mice. Roseomonas mucosa DL-1 and its extracellular polysaccharide have a protective effect on UVB-induced keratinocyte apoptosis in cell models and mouse models, can inhibit the increase in the transcription level of local inflammatory factors in skin lesions induced by UVB, and reduce the apoptosis of HaCaT cells caused by UVB irradiation. The present invention can provide a certain scientific basis for its drug development in antagonizing light damage.

Claims

1. Use of a live bacterial preparation of Roseomonas mucilaginosa as the sole active ingredient in the preparation of a drug for alleviating acute skin damage caused by UVB, wherein the live bacterial preparation of Roseomonas mucilaginosa is prepared by the following method: inoculating Roseomonas mucilaginosa into an R2A culture medium, activating at 25-37°C for 12-24 h, transferring the activated Roseomonas mucilaginosa into a fermentation culture medium, culturing at 30-37°C for 24-36 h to obtain a fermentation broth, centrifuging the fermentation broth, and then resuspending the broth in a dosing solvent to obtain the live bacterial preparation; The classification number of the mucilaginous roseomonas is mucilaginous roseomonas ( Roseomonas mucosa ), strain number is DL-1, which has been deposited in the General Microbiology Center of China General Microbiological Culture Collection Committee on October 26, 2022, and the deposit number is CGMCC No. 25967; the acute skin damage is acute skin damage caused only by UVB irradiation, and the UVB irradiation dose is 430 mJ / cm 2 .

2. The use according to claim 1, characterized in that: The number of live bacteria of Roseomonas mucilaginosa in the live bacteria preparation is 1×10 6 -1×10 9 CFU / mL.

3. The use according to claim 1, characterized in that: The live bacterial preparation of Roseomonas mucilaginosa reduces the oxidative stress level and cell apoptosis of HaCaT cells caused by UVB irradiation.

4. The use according to claim 1, characterized in that: The live bacterial preparation of Roseomonas mucilaginosa improves erythema, edema, exudation and scab on the back skin of C57BL / 6 mice induced by UVB irradiation, inhibits apoptosis of keratinocytes in the back skin lesions caused by UVB irradiation, and reduces the transcription level of inflammatory factors in the skin lesions.

5. Use of Roseomonas mucilaginosa exopolysaccharide as the sole active ingredient in the preparation of a drug for alleviating acute skin damage caused by UVB, wherein the Roseomonas mucilaginosa exopolysaccharide is prepared by the following method: inoculating Roseomonas mucilaginosa into R2A culture medium, activating at 25-37°C for 12-24 h, transferring the activated Roseomonas mucilaginosa into fermentation medium, culturing at 30-37°C for 24-36 h to obtain a fermentation broth, sterilizing, deproteinizing, precipitating with anhydrous ethanol, and separating and purifying the fermentation broth with DEAE centrifugal exchange resin to obtain the exopolysaccharide; The classification number of the mucilaginous roseomonas is mucilaginous roseomonas ( Roseomonas mucosa ), strain number is DL-1, which has been deposited in the General Microbiology Center of China General Microbiological Culture Collection Committee on October 26, 2022, and the deposit number is CGMCC No. 25967; the acute skin damage is acute skin damage caused only by UVB irradiation, and the UVB irradiation dose is 430 mJ / cm 2 .

6. The use according to claim 5, characterized in that: The Roseomonas mucilaginosa exopolysaccharide reduces the oxidative stress and apoptosis of HaCaT cells caused by UVB irradiation, and reduces the transcription level of inflammatory factors in HaCaT cells induced by UVB irradiation.

7. The use according to claim 5, characterized in that: The Roseomonas mucilaginosa exopolysaccharide inhibits the increase in the transcription level of type I interferon IFN-β caused by UVB irradiation.

8. The use according to claim 5, characterized in that: The Roseomonas mucilaginosa exopolysaccharide improves erythema, edema, exudation and scab on the back skin of C57BL / 6 mice induced by UVB irradiation, inhibits apoptosis of keratinocytes in the back skin lesions caused by UVB irradiation, and reduces the transcription level of inflammatory factors in the skin lesions.

9. The use according to claim 5, characterized in that: The weight average molecular weight of the extracellular polysaccharide is 3000-3500 Da.

10. The use according to claim 9, characterized in that: The monosaccharide composition of the extracellular polysaccharide includes arabinose, rhamnose, galactose, glucose, xylose, mannose, ribose, galacturonic acid, glucuronic acid, mannuronic acid and guluronic acid.